Keywords cGAS–STING pathway chemotherapy (ChX) cytotoxic T lymphocytes (CTLs) dendritic cells (DCs) immune checkpoint inhibitors (ICIs) immunogenic cell death (ICD) malignant melanoma radiation therapy (RT) stereotactic body radiation therapy (SBRT) tumour microenvironment (TME)